FG Eyes Gene Therapy Breakthrough: Nigeria Moves Toward CAR-T Cancer Treatment Revolution
Mirian Gom 
ABUJA, Nigeria – The Federal Government has announced plans to adopt cutting-edge gene therapy, including Chimeric Antigen Receptor (CAR) T-cell technology, in a move to transform advanced healthcare delivery in Nigeria.
Minister of State for Health, Dr. Iziaq Salako, disclosed this on Monday during a high-level engagement on emerging medical technologies in Abuja, highlighting the need for Africa to catch up with global innovation.
He noted that limited adoption of advanced treatments has left many patients without access to life-saving therapies.
“Africa has lagged behind in adopting innovative treatments, but engaging these technologies will strengthen our health systems,” Salako said.
CAR-T cell therapy, a form of regenerative medicine, involves modifying a patient’s immune cells to fight diseases such as cancer and genetic disorders, offering the potential for one-time curative treatment.
The Director-General of the National Institute for Pharmaceutical Research and Development (NIPRD), Dr. Obi Adigwe, emphasised the role of research and innovation in addressing Nigeria’s healthcare challenges.
Meanwhile, the Executive Director of Caring Cross, Dr. Boro Dropulic, said local production of gene therapies would reduce dependence on foreign facilities, improve access, and build skilled manpower.
“By producing these therapies locally, patients can receive treatment faster and more efficiently,” he said.
The initiative is also expected to reduce medical tourism, create high-value jobs, and position Nigeria as a regional hub for advanced medical innovation.
Salako added that Africa remains the only continent yet to deploy CAR-T therapy at scale, stressing that strong political will and partnerships are key to achieving this milestone.
About the Author
Edino Chubiyo Cornelius 
Otamere Gladness 